Comment on the article “Age and liver transplantation”

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.
Volume 67, Issue 3, Pages (September 2017)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
m-TOR inhibitors: What role in liver transplantation?
Liver transplantation using Donation after Cardiac Death donors
m-TOR inhibitors: What role in liver transplantation?
Primary prevention of variceal haemorrhage: A pharmacological approach
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 51, Issue 3, Pages (March 2007)
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
Mesenchymal stromal cell therapy for liver diseases
Reply to: “DCD consensus and futility in liver transplantation”
The place of downstaging for hepatocellular carcinoma
Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology 
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Quality measurement and improvement in liver transplantation
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 58, Issue 3, Pages (March 2013)
Volume 62, Issue 3, Pages (March 2015)
Volume 44, Issue 4, Pages (April 2006)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Age and liver transplantation
Reply to: “It takes two “eyes” to see in depth”
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immigration and viral hepatitis
Volume 57, Issue 3, Pages (September 2012)
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
The use of hemospray in portal hypertensive bleeding; a case series
Volume 66, Issue 4, Pages (April 2017)
m-TOR inhibitors: What role in liver transplantation?
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Donor-recipient matching: Myths and realities
Chimeric mouse model of hepatitis B virus infection
The relationship between age and fat infiltration in liver and muscle
Genetics of hepatocellular carcinoma: The next generation
Rocuronium plasma concentrations during three phases of liver transplantation: relationship with early postoperative graft liver function†‡  L. Gao, I.
MELD: the holy grail of organ allocation?
Outcomes in liver transplantation: Does sex matter?
Volume 64, Issue 6, Pages (June 2016)
Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child
Presentation transcript:

Comment on the article “Age and liver transplantation” Fabio Ferla, Andrea Lauterio, Riccardo De Carlis, Stefano Di Sandro, Niccolò Petrucciani, Laura Benuzzi, Luciano De Carlis  Journal of Hepatology  Volume 70, Issue 6, Pages 1305-1306 (June 2019) DOI: 10.1016/j.jhep.2019.02.007 Copyright © 2019 European Association for the Study of the Liver Terms and Conditions

Fig 1 Percentage of liver transplants performed in recipients over 65 years old in Europe and USA between 2002 and 2016. Light blue line: regression line for ELTR data (r2 = 0.94; slope = 0.616 [95% CI 0.523–0.710]; intercept = −1,228.741 [95% CI −1,416.321 to −1,041.161]). Blue line: regression line for UNOS data (r2 = 0.92; slope = 0.741 [95% CI 0.610 to 0.873]; intercept = − 1,477.119 [95% CI −1,741.511 to −1,212.726]). ELTR, European Liver Transplant Register; UNOS, United Network for Organ Sharing. Journal of Hepatology 2019 70, 1305-1306DOI: (10.1016/j.jhep.2019.02.007) Copyright © 2019 European Association for the Study of the Liver Terms and Conditions